戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  B lymphocytes that are deleted by anti-CD20 cotherapy.
2 4%) for current users of coxibs without such cotherapy.
3 3 (24.7%) prescribed an NS-NSAID without GPA cotherapy.
4 , 347 (18.9%) prescribed dual coxib plus GPA cotherapy, 173 (9.4%) prescribed a nonselective NSAID (N
5 ment on YMRS) were significantly higher with cotherapy (67.7% vs 44.7%; P< .001).
6                                         Ucn2 cotherapy additionally increased urine potassium and cre
7 urrent users of NSAIDs with gastroprotective cotherapy and 40% (23%-54%) for current users of coxibs
8  Overall adverse event rates were 77.6% with cotherapy and 67.9% with monotherapy.
9 hrombotic without the requirement of aspirin cotherapy and may provide benefits even to the aspirin-n
10 otherapy and/or gastroprotective agent (GPA) cotherapy, and 1,207 (65.8%) received coxibs.
11 bed a nonselective NSAID (NS-NSAID) plus GPA cotherapy, and 453 (24.7%) prescribed an NS-NSAID withou
12 iatal tissue analyses showed that nalbuphine cotherapy blocks several molecular correlates of LID, in
13                 Results show that indeed the cotherapy eradicates the complete population of MDR canc
14 e-2 inhibitors for patients who need aspirin cotherapy for the prevention of arterial thrombus format
15 were significantly higher for the olanzapine cotherapy group included somnolence, dry mouth, weight g
16 r remission rates in the MTX and other DMARD cotherapy groups (8% and 5%, respectively) as in the mon
17 odel the response in the MTX and other DMARD cotherapy groups relative to the monotherapy group separ
18 ent users of NSAIDs with no gastroprotective cotherapy had an adjusted incidence of peptic ulcer hosp
19                                   Olanzapine cotherapy improved 21-item Hamilton Depression Rating Sc
20  score of > or = 20 at baseline), olanzapine cotherapy improved HAMD-21 scores by 10.31 points compar
21                                   Olanzapine cotherapy improved patients' YMRS total scores significa
22                      Calcium is an essential cotherapy in osteoporosis treatment.
23 ximab guidelines suggest that MTX be used as cotherapy, in clinical practice, both monotherapy and co
24                                 Fibrinolytic cotherapy is therefore a rapidly translatable strategy f
25 alproate therapy, were randomized to receive cotherapy (olanzapine + mood-stabilizer) or monotherapy
26  NSAIDs combined with recommended anti-ulcer cotherapy or use of a selective cyclooxygenase 2-inhibit
27              The decrease was due to less GI cotherapy (OR = 0.82 [0.69-0.97]).
28 strointestinal complications, recognition of cotherapies that could reduce NSAID toxicity, and, most
29 e in diagnostics and as leads for anticancer cotherapies, used as enhancements of alkylating agents i
30                 More interestingly, when the cotherapy was combined with the properties of nanopartic
31          The most common adverse events with cotherapy were unpleasant taste, headache, dry mouth, an
32                                              Cotherapy with AICAR and MTX could represent a novel str
33 , in clinical practice, both monotherapy and cotherapy with DMARDs other than MTX are used.
34 MTX and, to a lesser extent, other DMARDs as cotherapy with etanercept was associated with a higher l
35 ieving a higher EULAR response category with cotherapy with MTX (odds ratio [OR] 2.0, 95% confidence
36                                              Cotherapy with MTX or another DMARD produced significant
37 uld be dependent on drug exposure and not on cotherapy with nevirapine.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。